Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis

Cancer clinical trial eligibility criteria may create patient populations studied in trials that do not reflect the patient populations treated in the real-world setting. Follicular lymphoma (FL) is an indolent lymphoma with heterogeneous presentations across a broad range of individuals, resulting...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Danny, Fatola, Tolulope, Toure, Ahmed, Flowers, Christopher R., Link, Brian, Friedberg, Jonathan W., Cohen, Jonathon B., Kahl, Brad, Lossos, Izidore S., Nastoupil, Loretta, Maurer, Matthew J., Cerhan, James R., Martin, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Health Services and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636310/
https://www.ncbi.nlm.nih.gov/pubmed/35793440
http://dx.doi.org/10.1182/bloodadvances.2022007687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636310/
https://www.ncbi.nlm.nih.gov/pubmed/35793440
http://dx.doi.org/10.1182/bloodadvances.2022007687

Ejemplares similares